nd genetic disorder
Foetal abnormalitiesa,b
General disorders and administration site conditions
Asthenia, Fatigue, Pyrexia, Pain, Mucosal inflammation
Lethargy
Investigations
Weight decreased
When events were noted as both all grade and grade 3-5 adverse drug reactions in clinical trials, the highest frequency observed in patients has been reported. Data are unadjusted for the differential time on treatment.
a For further information please refer to Table 3 'Adverse reactions reported in post-marketing setting.'
b Terms represent a group of events that describe a medical concept rather than a single condition or MedDRA (Medical Dictionary for Regulatory Activities) preferred term. This group of medical terms may involve the same underlying pathophysiology (e.g. arterial thromboembolic reactions include cerebrovascular accident, myocardial infarction, transient ischaemic attack and other arterial thromboembolic reactions).
c Based on a substudy from NSABP C-08 with 295 patients
d For additional information refer below within section "Further information on selected serious adverse reactions."
e Recto-vaginal fistulae are the most common fistulae in the GI-vaginal fistula category.
f Observed in pediatric population only
Table 2: Severe Adverse Reactions by Frequency
System organ class
Very Common
Common
Uncommon
Rare
Very Rare
Frequency Not Known
Infections and infestations
Sepsis, Cellulitis, Abscessa,b, Infection, Urinary tract infection
Necrotising fasciitisc
Blood and lymphatic system disorders
Febrile neutropenia, Leucopenia, Neutropeniaa, Thrombo-cytopenia
Anaemia, Lymphopenia
Immune system disorders
Hypersensitivity, infusion reactions a,b,c
Metabolism and nutrition disorders
Dehydration
Nervous system disorders
Peripheral sensory neuropathya
Cerebrovascular accident, Syncope, Somnolence, Headache
Posterior reversible encephalopathy syndrome a,b,c, Hypertensive encephalopathyc
Cardiac disorders
Congestive heart failurea,b, Supraventricular tachycardia
Vascular disorders
Hypertensiona,b
Thromboembolism arteriala,b, Haemorrhagea,b, Thromboembolism (venous)a,b
Deep vein thrombosis
Renal thrombotic microangiopathyb,c
Respiratory, thoracic and mediastinal disorders
Pulmonary haemorrhage/ Haemoptysisa,b, Pulmonary embolism, Epistaxis, Dyspnoea, Hypoxia
Pulmonary hypertensionc, Nasal septum perforationc
Gastroint